Serum Institute's second COVID vaccine likely to be launched in September
Updated : March 27, 2021 04:14 PM IST
He further said that it has been tested against African and UK variants of Covid-19 and has an overall efficacy of 89 percent.
"Hope to launch by September 2021!" the CEO of world's biggest Covid-19 vaccine maker said.
Covovax is the protein-based COVID-19 vaccine developed by Novavax, headquartered in the US.
Published : March 27, 2021 04:13 PM IST